Improving HPV vaccination rates among adolescents
The STOP-HPV Scale-Up Study
This study is all about helping doctors talk to parents better about the HPV vaccine so that more teens aged 13-17 can get vaccinated, making it easier for families to understand and feel good about the shot.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11058382 on NIH RePORTER |
What this research studies
This research focuses on increasing the HPV vaccination rates among adolescents aged 13-17 by addressing barriers related to clinician communication and office systems. It involves training clinicians on effective communication techniques to alleviate parental vaccine hesitancy and implementing workflow changes in primary care practices. The study will adapt two promising strategies for deployment by health systems, aiming to enhance the overall vaccination process. By partnering with health systems and using a mixed-methods approach, the research seeks to evaluate the effectiveness of these strategies in real-world settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 13-17 who are eligible for the HPV vaccine and their parents who may have concerns about vaccination.
Not a fit: Patients who are older than 17 years or those who have already completed the HPV vaccination series may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase HPV vaccination rates, thereby reducing the incidence of HPV-related cancers in adolescents.
How similar studies have performed: Previous research has shown success in improving vaccination rates through clinician training and system-level changes, indicating that this approach has potential for effectiveness.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Szilagyi, Peter G — University of California Los Angeles
- Study coordinator: Szilagyi, Peter G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.